Financial statements Shiraz Pharm

Balance sheet of Shiraz Pharm

Company age:
Age:
6 y. 4 m. 27 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of SHIRAZ PHARM

Year
2019
2019
2021
2022
2023
Total assets 57 133,12 3 955 935,42 2 291 918,73 2 310 050,08 2 758 522,79
A. Fixed assets 0,00 77 322,01 55 640,79 65 060,08 50 629,86
B. Current assets 57 133,12 3 878 613,41 2 236 277,94 2 244 990,00 2 707 892,93
C. Share capital contributions (basic funds) - - - - 0,00
D. Own shares (stocks) - - - - 0,00
Total liabilities 57 133,12 3 955 935,42 2 291 918,73 2 310 050,08 2 758 522,79
A. Equity -32 150,10 620 722,69 1 616 284,18 1 834 100,04 2 401 239,08
B. Liabilities and provisions for liabilities 89 283,22 3 335 212,73 675 634,55 475 950,04 357 283,71
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 89 283,22 3 335 212,73 675 634,55 475 950,04 357 283,71
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.